Health
Here’s a rapid-fire update on what Trump will mean for all 33 portfolio stocks
Here’s a rapid-fire update on all the stocks in Jim Cramer’s Charitable Trust, the portfolio we use for the CNBC Investing Club. During the November Monthly Meeting on Thursday, Jim looked at how Donald Trump’s return to the White House could impact each company — good, bad or not much at all. Apple : If […]
Read More
Smart ring leader Oura plans international push as CEO touts new features and thinking on hardware
The Oura Ring 4 Courtesy: Oura LISBON — Samsung’s foray into smart rings isn’t concerning the boss of the product category’s pioneer, Oura — in fact, Tom Hale says he’s seeing a boost in business. “I’m sure that a major tech company making an announcement saying: ‘Hey, this is a category that matters. It’s going to be […]
Read More
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
The office building of biopharmaceutical company AstraZeneca is being seen in Shanghai, China, on May 23, 2024. Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. AstraZeneca said it is doubling down […]
Read More
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Omar Marques | Lightrocket | Getty Images Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide. One analyst said the additional data suggests a new potential safety risk tied to the drug. But others said the share […]
Read More
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Signage at 23andMe headquarters in Sunnyvale, California, U.S., on Wednesday, Jan. 27, 2021. David Paul Morris | Bloomberg | Getty Images 23andMe on Tuesday reported declining revenue in its most recent quarter, a day after the company said it will cut 40% of its workforce and shutter its therapeutics business as part of a business […]
Read More
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Aykut Karahan | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Friday! Buried in the election news this week was new data from drugmakers vying to enter the booming weight […]
Read More
How Trump’s victory could change abortion rights in America
Anti-abortion demonstrators listen to President Donald Trump as he speaks at the 47th annual “March for Life” in Washington, D.C., Jan. 24, 2020. Olivier Douliery | Afp | Getty Images Voters in seven out of 10 states approved ballot measures this week to safeguard abortion rights, a hot-button issue that helped drive Americans to the […]
Read More
FDA proposes ending use of decongestant found in many cold, allergy medicines
A bottle of Vicks DayQuil cold and flu medicine containing phenylephrine is displayed for sale in a CVS Pharmacy store in Hawthorne, California, on Sept. 12, 2023. Patrick T. Fallon | AFP | Getty Images The Food and Drug Administration on Thursday proposed ending the use of a common ingredient found in many popular over-the-counter […]
Read More
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
Moderna on Thursday posted a surprise profit for the third quarter, smashing Wall Street estimates, as its cost-cutting efforts took hold and sales of its Covid vaccine came in higher than expected. The biotech company posted a net income of $13 million, or 3 cents per share, for the third quarter. That compares with a […]
Read More
CVS posts mixed results, holds off on guidance in Joyner’s first earnings report as CEO
A person walks by a CVS Pharmacy store in Manhattan, New York, on Nov. 15, 2021. Andrew Kelly | Reuters CVS Health on Wednesday reported mixed third-quarter results as higher medical costs squeezed its bottom line. The earnings report is CEO David Joyner’s first at the helm of the troubled retail drugstore chain. The company […]
Read More